Evaluation of thiol-disulfide homeostasis in active ankylosing spondylitis patients

Braun, 2007, Ankylosing spondylitis, The Lancet, 369, 1379, 10.1016/S0140-6736(07)60635-7 Machado, 2011, Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores, Ann Rheum Dis, 70, 47, 10.1136/ard.2010.138594 Stolwijk, 2012, Epidemiology of spondyloarthritis, Rheum Dis Clin North Am, 38, 441, 10.1016/j.rdc.2012.09.003 Ziade, 2017, HLA B27 antigen in Middle Eastern and Arab countries: systematic review of the strength of association with axial spondyloarthritis and methodological gaps, BMC Musculoskelet Disord, 18, 280, 10.1186/s12891-017-1639-5 Erel, 2014, A novel and automated assay for thiol/disulphide homeostasis, Clin Biochem, 47, 326, 10.1016/j.clinbiochem.2014.09.026 Poole, 2015, The basics of thiols and cysteines in redox biology and chemistry, Free Radic Biol Med, 80, 148, 10.1016/j.freeradbiomed.2014.11.013 Turell, 2013, The thiol pool in human plasma: the central contribution of albumin to redox processes, Free Radic Biol Med, 65, 244, 10.1016/j.freeradbiomed.2013.05.050 Erel, 2020, Thiol-disulfide homeostasis: an integrated approach with biochemical and clinical aspects, Turk J Med Sci, 50, 1728, 10.3906/sag-2003-64 Linden, 1984, Evaluation of diagnostic criteria for ankylosing spondylitis, Arthritis Rheum, 27, 361, 10.1002/art.1780270401 Hansen, 2009, Quantifying the global cellular thiol-disulfide status, Proc Natl Acad Sci U S A, 106, 422, 10.1073/pnas.0812149106 Go, 2011, Cysteine/cystine redox signaling in cardiovascular disease, Free Radic Biol Med, 50, 495, 10.1016/j.freeradbiomed.2010.11.029 Matteucci, 2010, Thiol signalling network with an eye to diabetes, Molecules, 15, 8890, 10.3390/molecules15128890 Prabhu, 2014, Cysteine catabolism: a novel metabolic pathway contributing to glioblastoma growth, Cancer Res, 74, 787, 10.1158/0008-5472.CAN-13-1423 Tetik, 2010, Determination of oxidant stress in plasma of rheumatoid arthritis and primary osteoarthritis patients, Indian J Biochem Biophys, 47 Smeyne, 2013, Glutathione metabolism and Parkinson's disease, Free Radic Biol Med, 62, 13, 10.1016/j.freeradbiomed.2013.05.001 Ozgocmen, 2004, Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis, Rheumatol Int, 24, 80, 10.1007/s00296-003-0335-y Stanek, 2010, Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis, Clin Biochem, 43, 566, 10.1016/j.clinbiochem.2009.12.019 Pishgahi, 2020, Immunological and oxidative stress biomarkers in ankylosing spondylitis patients with or without metabolic syndrome, Cytokine, 128, 155002, 10.1016/j.cyto.2020.155002 Ueland, 1996, Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status – a possible element of the extracellular antioxidant defense system, J Nutr, 126, 1281S, 10.1093/jn/126.suppl_4.1281S Lu, 2014, The thioredoxin antioxidant system, Free Radic Biol Med, 66, 75, 10.1016/j.freeradbiomed.2013.07.036 Dogru, 2016, Thiol/disulfide homeostasis in patients with ankylosing spondylitis, Bosn J Basic Med Sci, 16, 187, 10.17305/bjbms.2016.1001 Baykara, 2019, Evaluation of serum thiol/disulfide homeostasis in patients with ankylosing spondylitis by a novel method, North Clin Istanb, 6, 348 Gonzalez-Rey, 2012, Does non-steroidal anti-inflammatory (NSAID) ibuprofen induce antioxidant stress and endocrine disruption in mussel Mytilus galloprovincialis?, Environ Toxicol Pharmacol, 33, 361, 10.1016/j.etap.2011.12.017 Mahmood, 2009, Non-steroidal anti-inflammatory drugs (NSAIDs), free radicals and reactive oxygen species (ROS): a review of literature, MJBU, 27, 46, 10.33762/mjbu.2009.49041 Nawaz, 2020, Chronological effects of non-steroidal anti-inflammatory drug therapy on oxidative stress and antioxidant status in patients with rheumatoid arthritis, Clin Rheumatol, 1 Lemarechal, 2006, Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy, Clin Chim Acta, 372, 147, 10.1016/j.cca.2006.04.002 Pergel, 2012, Anti-inflammatory and antioxidant effects of infliximab in a rat model of intestinal ischemia/reperfusion injury, Toxicol Ind Health, 28, 923, 10.1177/0748233711427056 Machado, 2013, Is it time to replace BASDAI with ASDAS?, Nat Rev Rheumatol, 9, 388, 10.1038/nrrheum.2013.93 Jun, 2016